Is Inventurus Knowledge Solutions Ltd (IKS) a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Inventurus Knowledge Solutions Ltd is a good quality company .

Is Inventurus Knowledge Solutions Ltd (IKS) undervalued or overvalued?

The key valuation ratios of Inventurus Knowledge Solutions Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Inventurus Knowledge Solutions Ltd (IKS) share price return in the past 10 years?

Data is not available for this company

Is Inventurus Knowledge Solutions Ltd (IKS) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Inventurus Knowledge Solutions Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of Inventurus Knowledge Solutions Ltd (IKS)?

Company share prices are keep on changing according to the market conditions. The current trading price of Inventurus Knowledge Solutions Ltd (IKS) on 10-Apr-2026 16:59:59 at 16:59 is 1540.75.

What is the market cap of Inventurus Knowledge Solutions Ltd (IKS)?

Market capitalization is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Apr-2026 at 16:59, the market cap of Inventurus Knowledge Solutions stood at Rs. 26435.13 Cr.

What is the P/E ratio of Inventurus Knowledge Solutions?

The latest standalone P/E ratio of Inventurus Knowledge Solutions as of 10-Apr-2026 is 53.15.

What is the P/B ratio of Inventurus Knowledge Solutions Ltd (IKS)?

The latest standalone P/B ratio of Inventurus Knowledge Solutions Ltd (IKS) as of 10-Apr-2026 is 16.26.

What is the 52-week high and low of Inventurus Knowledge Solutions Ltd (IKS)?

The 52-week high of Inventurus Knowledge Solutions Ltd (IKS) is Rs. 1875.25 and the 52-week low is Rs. 1262.35.

What is the TTM revenue of Inventurus Knowledge Solutions Ltd (IKS)?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Inventurus Knowledge Solutions is Rs. 1369.06 (Cr.).

Inventurus Knowledge Solutions Ltd (IKS) Share Analysis – Quality, Growth & Valuation Zone & DeciZen Rating

Name: Inventurus Knowledge Solutions Ltd (IKS)
Brand: Inventurus Knowledge Solutions

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	70.4%	29.8%	20.5%	65.5%	65.4%	51.4%	47.9%	50.7%	50.5%	37.7%	-
Value Creation Index ⓘ	5.3	1.7	0.8	4.8	4.8	3.6	3.3	3.5	3.5	2.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	203	230	262	352	388	418	560	759	873	973	1,369
Sales YoY Gr.	-	13.4%	13.6%	34.6%	10.1%	7.8%	34%	35.5%	15%	11.5%	-
Adj EPS ⓘ	2.3	1.2	0.9	5.4	7.6	8.5	12	16.5	20	19.5	29
YoY Gr.	-	-45.6%	-27.4%	498.9%	41.4%	11.3%	41.8%	37%	21.6%	-2.7%	-
BVPS (₹) ⓘ	0.4	1.9	3.4	9.7	13.6	22.4	30.1	37.7	48.2	69.9	94.7
Adj Net Profit ⓘ	37.4	20.6	14.5	86.9	124	139	204	277	339	332	497
Cash Flow from Ops. ⓘ	51.6	41.7	45.6	99.4	141	168	237	248	119	274	-
Debt/CF from Ops. ⓘ	1.5	1.5	1.1	0	0	0	0	0	1.2	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	19%	20.2%	20.2%	11.5%
Adj EPS ⓘ	26.9%	20.7%	17.5%	-2.7%
BVPSⓘ	79.6%	38.8%	32.5%	45.1%
Share Price	-	-	-	14.7%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-281.4	110.2	32.9	78.2	62.9	45.9	45.7	47.9	46.2	32.3	35.2
Op. Profit Mgn % ⓘ	27.5	18.2	14	28.8	35.7	39.7	41.7	42	45.6	43.9	47.7
Net Profit Mgn % ⓘ	18.4	9	5.6	24.7	32	33.2	36.4	36.5	38.8	34.1	36.3
Debt to Equity ⓘ	13.3	2	1	0	0	0	0	0	0.2	0	-
Working Cap Days ⓘ	127	119	99	83	101	118	116	93	104	141	74
Cash Conv. Cycle ⓘ	85	63	29	6	6	8	7	8	40	77	53

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 20.21%

Net Profit is growing at healthy rate in last 3 years 17.48%

Sales growth is good in last 4 quarters at 58.11%

Return on Equity has declined versus last 3 years average to 35.20%

	Standalone	Consolidated
TTM EPS (₹)	29	38.7
TTM Sales (₹ Cr.)	1,369	3,060
BVPS (₹) ⓘ	94.7	141.4
Reserves (₹ Cr.) ⓘ	1,608	2,410
P/BV ⓘ	16.26	10.89
PE ⓘ	53.15	39.85

From the Market
52 Week Low / High (₹)	1262.35 / 1875.25
All Time Low / High (₹)	1226.15 / 2190.00
Market Cap (₹ Cr.)	26,435
Equity (₹ Cr.)	17.2
Face Value (₹)	1
Industry PE ⓘ	20.6

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	203	230	262	352	388	418	560	759	873	973
Operating Expenses > ⓘ +	149	189	225	253	252	252	329	444	478	546
Manufacturing Costs	4	5	5	6	6	4	5	8	9	11
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	112	150	179	202	211	222	285	359	388	432
Other Costs > ⓘ	34	34	41	45	35	26	39	77	81	103
Operating Profit > ⓘ	54	41	36	100	135	166	231	316	394	427
Operating Profit Margin (%)	26.6%	18.0%	13.9%	28.3%	35.0%	39.6%	41.3%	41.6%	45.2%	43.8%
Other Income > ⓘ +	0	1	12	24	31	16	21	28	33	15
Exceptional Items > ⓘ	0	0	0	0	0	0	-20	-31	0	0
Interest > ⓘ	8	6	6	4	7	7	6	5	16	11
Depreciation > ⓘ	10	15	28	33	36	26	19	20	22	29
Profit Before Tax > ⓘ	36	20	14	86	123	148	208	288	390	402
Tax > ⓘ	0	0	0	0	1	9	19	34	53	70
Profit After Tax	36	20	14	86	122	139	189	253	337	332
PAT Margin (%)	17.8%	8.8%	5.5%	24.4%	31.5%	33.3%	33.7%	33.4%	38.6%	34.1%
Adjusted EPS (₹)	2.2	1.2	0.9	5.3	7.5	8.5	11.1	15.1	19.9	19.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	16%	14%	48%	66%	50%	0%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	6	31	54	156	221	367	510	635	815	1,190
Share Capital ⓘ	8	8	8	8	8	8	17	17	17	17
Reserves ⓘ	-2	23	46	148	213	359	493	618	798	1,173
Debt +	65	42	38	1	0	0	0	0	138	0
Long Term Debt	56	23	10	1	0	0	0	0	0	0
Short Term Debt	9	19	28	0	0	0	0	0	138	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	5	8	24	8	19	8	16	21	16	31
Others Liabilities ⓘ	75	76	40	27	83	64	100	86	146	140
Total Liabilities ⓘ	151	158	155	193	323	440	626	741	1,116	1,361
Fixed Assets
Net Fixed Assets ⓘ +	32	42	81	52	90	72	63	49	116	101
Gross Block	59	84	108	112	174	173	174	171	256	248
Accumulated Depreciation	27	42	27	60	84	101	111	121	141	147
CWIP ⓘ	26	36	0	0	0	0	0	0	0	10
Investments ⓘ	4	4	5	6	5	16	16	19	473	734
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	56	40	40	17	37	26	38	66	198	309
Cash Equivalents	12	1	1	44	103	204	336	495	205	85
Others Assets ⓘ	19	34	28	75	86	121	172	112	123	122
Total Assets ⓘ	151	158	155	193	323	440	626	741	1,116	1,361

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	52	42	46	99	141	168	237	248	119	274
PBT ⓘ	36	20	14	86	123	148	208	288	390	402
Adjustment ⓘ	20	21	35	40	42	18	23	29	6	43
Changes in Working Capital ⓘ	3	3	-0	-11	1	18	44	-19	-203	-106
Tax Paid ⓘ	-7	-3	-4	-16	-25	-17	-37	-50	-73	-65
Cash Flow From Investing Activity ⓘ +	-38	-35	-29	-12	-80	-165	-81	-141	-149	-104
Capex	-39	-36	-29	-5	-11	104	-9	-8	-20	-36
Net Investments	0	0	0	-6	-72	-274	-83	-156	300	173
Others ⓘ	0	0	0	0	4	5	11	23	-429	-241
Cash Flow From Financing Activity ⓘ +	-2	-18	-16	-51	-36	-32	-54	-148	-186	24
Net Proceeds from Shares ⓘ	2	5	0	2	1	2	4	15	3	67
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-8	-6	-6	-4	-6	-7	-6	-14	-15	-11
Dividend Paid ⓘ	0	0	0	0	-19	-19	-44	0	-165	0
Others ⓘ	5	-17	-10	-49	-12	-9	-9	-149	-9	-32
Net Cash Flow ⓘ	12	-12	1	37	25	-30	102	-40	-216	194

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	0	108.18	33.62	81.51	64.82	47.3	43.06	44.29	46.48	33.11
ROCE (%)	70.37	29.81	20.54	65.46	65.38	51.39	47.86	50.68	50.53	37.67
Asset Turnover Ratio	1.62	1.49	1.67	2.02	1.5	1.1	1.05	1.11	0.94	0.79
PAT to CFO Conversion(x)	1.44	2.1	3.29	1.15	1.16	1.21	1.25	0.98	0.35	0.83
Working Capital Days
Receivable Days	102	77	56	30	25	28	21	25	55	95
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

About Inventurus Knowledge Solutions Ltd

Inventurus Knowledge Solutions limited was incorporated on September 5, 2006, as a private limited company under the Companies Act, 1956, with the name, ‘Inventurus Knowledge Solutions Private Limited’ pursuant to a certificate of incorporation issued by the Registrar of Companies, Goa, Daman and Diu. pursuant to a special resolution dated June 10, 2019. On the conversion of the company to a public limited company, pursuant to a resolution passed by its Board on October 14, 2022 and its Shareholders on October 17, 2022, the name of the company was changed to ‘Inventurus Knowledge Solutions Limited’, consequent to which a fresh certificate of incorporation dated November 4, 2022, was issued by the Registrar of Companies (RoC).

The company is a technology-enabled healthcare solutions provider and offer a care enablement platform assisting physician enterprises in the US, Canada and Australia, with a focus on the US markets. It is a partner for outpatient and inpatient care organizations, enabling healthcare organizations deliver superior clinical care, improve population health outcomes, and transition to the ‘fee for value’ model while optimizing their revenue and reducing operating costs. With the evolution and consolidation of the healthcare industry, it provides solutions that address these increasing tasks, or 'chores', and enable healthcare delivery enterprises to focus on their core focus of healthcare, by taking over chores that are necessary to manage their business. It does this through a blend of pragmatic technology and global human capital, with the aim of enabling healthcare delivery enterprises deliver better, safer and cost-effective care.

It offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Outpatient service facilities, also known as ambulatory care, provide medical care without requiring admission to a hospital or other facility, and include observation, consultation, diagnosis, rehabilitation, intervention, and treatment services. Inpatient care, refers to the provision of medical treatment for patients who have been admitted to a hospital or medical facility, requiring an overnight stay or an extended duration.

Business area of the company

Awards and accreditations

2019: Healthcare leadership award, 2019 by ABP news for contribution in the healthcare industry.
2020: L&D innovation and tech awards, 2020 by DISPRZ for best blended learning strategy.
2021: POSH awards, 2021 by KelpHR for being part of top 25 safest workplaces in India.
2021: TISS LeapVault award, 2021 in the best remote working program.
2022: 12th Aegis Graham Bell award, 2022 for being part of top three finalist in the category of innovation in Analytics.
2022: Technology Excellence award, 2022 for best data science project in the healthcare category.

History and milestones

2006: Incorporation of the company Investment by Rekha Jhunjhunwala, one of its Promoters.
2007: Onboarded its first client.
2009: Set up a new office space situated in an SEZ in Hyderabad, India.
2013: Set up a new office space situated in an SEZ in Mumbai, India.
2014: It turned EBITDA positive.
2015: Expanded its office space situated in an SEZ in Hyderabad, India.
2016: Registered ‘IKS Health’ brand and logo with the United States Patent and Trademark Office.
2022: Conversion of the company from Private Limited to Public Limited Company Crossed revenue of $100 million.
2023 Acquisition of Aquity Holdings, Inc. by IKS Inc.

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Inventurus Knowledge Solutions Ltd (IKS) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Inventurus Knowledge Share Price